Design Therapeutics, Inc. (DSGN)
NASDAQ·Healthcare·Biotechnology
$10.95
+3.99%
Mkt Cap $665.17M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$17.50
Range $14.00 – $21.00
Implied Upside
+59.8%
Consensus $17.50 vs current $10.95
NASDAQ·Healthcare·Biotechnology
$10.95
+3.99%
Mkt Cap $665.17M
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$17.50
Range $14.00 – $21.00
+59.8%
Consensus $17.50 vs current $10.95